Meet Dr. Edith Perez | Minority Health Month | Stand Up To Cancer Stand Up To Cancer 1:05 5 years ago 242 Скачать Далее
Dr. Edith Perez on the development of targeted therapies Breast Cancer Research Foundation 3:07 13 years ago 114 Скачать Далее
Dr. Edith Perez Discusses the Adjuvant Treatment of Breast Cancer OncLive 1:04 11 years ago 130 Скачать Далее
Translational Genomics: The Future is Now | Edith Perez, MD Pulmonary Fibrosis Foundation 33:58 4 years ago 214 Скачать Далее
Dr. Edith Perez Discusses BOLERO-1 Trial Results for HER2-Positive Breast Cancer OncLive 1:07 9 years ago 203 Скачать Далее
Dr. Edith Perez on Immune Checkpoint Inhibition in Triple-Negative Breast Cancer OncLive 1:25 9 years ago 619 Скачать Далее
Dr. Edith Perez Describes the Mayo Clinic Breast Cancer Translational Genomics Program OncLive 1:03 12 years ago 357 Скачать Далее
Dr. Edith Perez Discusses Adjuvant Chemotherapy Patient Selection OncLive 1:15 12 years ago 215 Скачать Далее
PFF Summit 2019 | Keynote Speaker Dr. Edith Perez Q&A Pulmonary Fibrosis Foundation 9:06 4 years ago 369 Скачать Далее
What Does the Future of Cancer Research Look Like \\ Edith Perez Lesbians Who Tech 10:20 8 years ago 249 Скачать Далее
Dr. Edith Perez on the Etirinotecan Pegol for HER2-Negative Breast Cancer OncLive 1:20 9 years ago 401 Скачать Далее
Conquering Cancer Personalized Medicine Is the Future \\ Edith Perez Lesbians Who Tech 9:19 7 years ago 56 Скачать Далее
Edith A. Perez, MD: Anti-HER2 Therapies Vital Options International 7:28 11 years ago 454 Скачать Далее
Dr. Edith Perez on a Phase III Trial Comparing Eribulin and Capecitabine OncLive 2:01 11 years ago 357 Скачать Далее
HER2 Positive Metastatic Breast Cancer Advances Vital Options International 8:11 13 years ago 3 528 Скачать Далее
Dr. Edith Perez Discusses Anti-HER2 Therapies -- 2012 SABCS Breast Cancer Answers® 16:17 11 years ago 3 064 Скачать Далее
Dr. Edith Perez on her Anticipated Results for ASCO and SABCS OncLive 1:08 13 years ago 119 Скачать Далее
